Drugs / HAVpur
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01349829 | Mar 2010 → Apr 2011 | hepatitis A virus infection | Crucell Holland BV | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HAVpur | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01349829 ↗ |
| Modality | Vaccine | “a Pediatric Presentation (0.25 ml) of the Virosomal Hepatitis A Virus (HAV) Vaccine HAVpur” NCT01349829 ↗ |